Display options
Cite
Song W, Kim CK, Park BK, et al. Impact of preoperative and postoperative membranous urethral length measured by 3 Tesla magnetic resonance imaging on urinary continence recovery after robotic-assisted radical prostatectomy. Can Urol Assoc J. 2017;11(3):E93-E99doi: 10.5489/cuaj.4035.
Song, W., Kim, C. K., Park, B. K., Jeon, H. G., Jeong, B. C., Seo, S. I., Jeon, S. S., Choi, H. Y., & Lee, H. M. (2017). Impact of preoperative and postoperative membranous urethral length measured by 3 Tesla magnetic resonance imaging on urinary continence recovery after robotic-assisted radical prostatectomy. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 11(3), E93-E99. https://doi.org/10.5489/cuaj.4035
Song, Wan, et al. "Impact of preoperative and postoperative membranous urethral length measured by 3 Tesla magnetic resonance imaging on urinary continence recovery after robotic-assisted radical prostatectomy." Canadian Urological Association journal = Journal de l'Association des urologues du Canada vol. 11,3 (2017): E93-E99. doi: https://doi.org/10.5489/cuaj.4035
Song W, Kim CK, Park BK, Jeon HG, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM. Impact of preoperative and postoperative membranous urethral length measured by 3 Tesla magnetic resonance imaging on urinary continence recovery after robotic-assisted radical prostatectomy. Can Urol Assoc J. 2017 Mar-Apr;11(3):E93-E99. doi: 10.5489/cuaj.4035. Epub 2017 Mar 16. PMID: 28360954; PMCID: PMC5365396.
Copy Download .nbib Format: NLM
Share it on

Can Urol Assoc J. 2017 Mar-Apr;11(3):E93-E99. doi: 10.5489/cuaj.4035. Epub 2017 Mar 16.

Impact of preoperative and postoperative membranous urethral length measured by 3 Tesla magnetic resonance imaging on urinary continence recovery after robotic-assisted radical prostatectomy.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Wan Song, Chan Kyo Kim, Byung Kwan Park, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Han Yong Choi, Hyun Moo Lee

Affiliations

  1. Department of Urology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Korea.
  2. Department of Radiology and Centre for Imaging Science, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Korea.

PMID: 28360954 PMCID: PMC5365396 DOI: 10.5489/cuaj.4035

Abstract

INTRODUCTION: We sought to investigate the impact of preoperative and postoperative membranous urethral length (MUL) on urinary continence using 3 Tesla (3T) magnetic resonance imaging (MRI) after robotic-assisted radical prostatectomy (RARP).

METHODS: Between 2008 and 2013, 190 men with RARP underwent preoperative and postoperative MRI. Patients who received adjuvant radiotherapy or who were lost to followup were excluded, leaving 186 patients eligible for analysis. Preoperative MUL was estimated from the prostate apex to the penile bulb, while postoperative MUL was estimated from the bladder neck to penile bulb. Patients with no pads or protection were considered to have complete continence. Logistic regression analysis was used to identify predictors associated with urinary incontinence at six and 12 months.

RESULTS: Age was commonly associated with urinary incontinence at six and 12 months. In addition, diabetes mellitus (DM) was another factor associated with urinary incontinence at 12 months. When adjusting these variables, preoperative MUL ≤16 mm (95% confidence interval [CI] 1.01-1.14; p=0.022), postoperative MUL ≤14 mm (95% CI 1.16-9.80; p=0.025) and percent change of MUL >18% (95% CI 1.17-7.23; p=0.021) were significantly associated with urinary incontinence at six months. However, at 12 months, preoperative MUL ≤13.5 mm (95% CI 1.85-19.21; p=0.003) and postoperative MUL ≤13 mm (95% CI 1.24-13.84; p=0.021) had impacts on urinary incontinence, but not percent change of MUL.

CONCLUSIONS: Preoperative and postoperative MUL were significantly associated with urinary continence recovery after RARP. Therefore, efforts to preserve MUL are highly recommended during surgery for optimal continence outcomes after RARP.

References

  1. Eur Urol. 2012 Sep;62(3):405-17 - PubMed
  2. Eur Urol. 2011 May;59(5):702-7 - PubMed
  3. BJU Int. 2015 Oct;116(4):577-83 - PubMed
  4. Oncol Lett. 2012 Jan;3(1):181-184 - PubMed
  5. BJU Int. 2011 Sep;108(6 Pt 2):1007-17 - PubMed
  6. Eur Urol. 2009 Apr;55(4):892-900 - PubMed
  7. Urologe A. 2013 Apr;52(4):527-32 - PubMed
  8. J Urol. 2012 Mar;187(3):945-50 - PubMed
  9. Neurourol Urodyn. 2012 Jun;31(5):646-51 - PubMed
  10. Eur Urol. 2011 Jun;59(6):985-96 - PubMed
  11. J Urol. 2010 Mar;183(3):1087-91 - PubMed
  12. Eur Urol. 2016 Mar;69(3):485-95 - PubMed
  13. Can J Urol. 2010 Jun;17(3):5200-5 - PubMed
  14. Neurourol Urodyn. 2015 Aug;34(6):527-32 - PubMed
  15. J Urol. 2002 Sep;168(3):1032-5 - PubMed
  16. Eur Urol. 2014 Mar;65(3):610-9 - PubMed
  17. J Urol. 2008 May;179(5):1907-11 - PubMed
  18. Int J Urol. 2013 Sep;20(9):889-95 - PubMed
  19. J Endourol. 2011 Jun;25(6):1025-30 - PubMed
  20. J Urol. 2007 Jul;178(1):208-11 - PubMed
  21. Urology. 2014 Sep;84(3):642-9 - PubMed
  22. Int J Urol. 2013 Nov;20(11):1052-63 - PubMed
  23. J Endourol. 2014 Aug;28(8):930-8 - PubMed
  24. J Urol. 2011 Jul;186(1):204-8 - PubMed
  25. Eur Urol. 2009 Mar;55(3):629-37 - PubMed
  26. J Urol. 2010 Sep;184(3):1028-33 - PubMed
  27. J Endourol. 2012 Jul;26(7):889-94 - PubMed
  28. J Urol. 2010 May;183(5):1803-7 - PubMed

Publication Types